Home Your basket
• CT scanning in "second lo...
   Price 5.50 €
• The rehabilitation of the...
   Price 10.50 €
• Peptide receptor radionuc...
   Price 14.00 €
• Neuroplasticity in the au...
   Price 10.50 €
• Cholesteatoma presenting ...
   Price 12.50 €
• Focus on the BPPV: Semont...
   Price 12.50 €
• Long term results of tymp...
   Price 5.50 €
• Epitympanic osteoma of th...
   Price 12.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Speech disorders, verbal ...
   Price 10.50 €
• Giant osteoma of the maxi...
   Price 8.50 €
• Transoral surgical treatm...
   Price 8.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Congenital anomalies of n...
   Price 14.00 €
• Transit time of swallowin...
   Price 10.50 €
• Total ossicular reconstru...
   Price 10.50 €
• Non-Hodgkin's lymphoma of...
   Price 5.50 €
• Detection and role of hum...
   Price 14.00 €
• Dehiscence of the superio...
   Price 10.50 €
• Treatment of children wit...
   Price 8.50 €
• Videonystagmography and v...
   Price 10.50 €
• The Voice Handicap Index:...
   Price 10.50 €
• A non-linear model of lar...
   Price 10.50 €
• Results of six years expe...
   Price 8.50 €
• Malignant melanoma of the...
   Price 10.50 €
• Viral assumption and inve...
   Price 10.50 €
• Mandibular reconstruction...
   Price 8.50 €
• Endoscopic-assisted retro...
   Price 10.50 €
• Respiratory epithelial ad...
   Price 12.50 €
• What is the effect of diz...
   Price 10.50 €
• A perceptual study of the...
   Price 8.50 €
• Desmoplastic ameloblastom...
   Price 5.50 €
• Cochlear implantation in ...
   Price 5.50 €
• Clinical signs and correl...
   Price 10.50 €
• Life after total laryngec...
   Price 8.50 €
• Decompression surgery for...
   Price 8.50 €
• Pleomorphic adenoma of th...
   Price 12.00 €
• A histopathologic evaluat...
   Price 8.50 €

Total Order 369.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2005 o

OTOLOGY

Influence of the relapse and remission periods on hearing status in children with minimal change nephrotic syndrome


Authors : Y. A. Bayazit, A. Balat, H. I. Pakir, E. Güler, M. Kanlikama (Ankara - Gaziantep)

Ref. : Rev Laryngol Otol Rhinol. 2005;126,3:171-173.

Article published in english
Downloadable PDF document english



Summary : Objective: Minimal change nephrotic syndrome (MCNS) is characterized by the onset of NS (Nephrotic Syndrome) without systemic disease, hypocomplementemia, or other serious signs of renal disease. Hearing status is not very well known in MCNS. Our objective was to address this question and to find out remission and relapse periods of the syndrome would affect the hearing of the patients. Methods and Patients: Otologic status of 26 children with clinical MCNS was investigated in relapse and remission periods using audiometry and tympanometry. The pure tones that were obtained at the frequencies 250, 500, 1000, 2000, 4000 and 6000 Hz were noted. Pure tone averages (PTAs) were calculated at 500, 1000, 2000 and 4000 Hz frequencies. Results: In both remission and relapse periods, PTA of the patients did not change and was 13 dB. The frequency specific pure tone results were not significantly different between the right and left ears of the patients as well as between the remission and relapse periods (p>0.05). In the relapsing and remission periods, type A tympanogram was encountered in 86.4% and 92.3% of the ears, respectively. Type B tympanogram was encountered in 11.5% and 3.8% of the ears in the relapsing and remission periods, respectively. Type C tympanogram was encountered in 3.8% of the ears both in the relapsing and remission periods. Differences between the tympanometry results were not significant (p>0.05). Conclusion: MCNS in childhood is not associated with an alteration in the hearing status, both in remission and relapse periods of the disease.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE